Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuroma, Acoustic 3 Surgical Wound Infection 2 Stomatitis 2 Nasopharyngeal Carcinoma 2 Breast Neoplasms 2 Sepsis 1 Neutropenia 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Colonic Neoplasms 1

Interventions

pegfilgrastim 30 Filgrastim 29 Cyclophosphamide 10 Docetaxel 8 pegylated granulocyte colony-stimulating factor 7 Etoposide 7 Cytarabine 7 Ciprofloxacin 5 Cefepime 5 eflapegrastim 4 Vancomycin 4 Leucovorin 4 Granulocyte Colony-Stimulating Factor 4 Fluorouracil 4 Doxorubicin 4 Peripheral Blood Stem Cell Transplantation 3 Mitoxantrone 3 Methotrexate 3 Levofloxacin 3 Irinotecan 3 Idarubicin 3 Daunorubicin 3 Cyclosporine 3 Caspofungin 3 Carboplatin 3 trifluridine tipiracil drug combination 2 plerixafor 2 liposomal amphotericin B 2 Vincristine 2 Topotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neutropenia × Gentamicins × Clear all

NCT01931592 2017-05-08

CLEAR

University of Cologne

Phase 2/3 Terminated

Neoplasms, Neutropenia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡